Full metadata record
DC FieldValueLanguage
dc.creatorMazo, M. (Manuel)-
dc.creatorPelacho, B. (Beatriz)-
dc.creatorProsper-Cardoso, F. (Felipe)-
dc.date.accessioned2011-05-25T15:12:08Z-
dc.date.available2011-05-25T15:12:08Z-
dc.date.issued2010-
dc.identifier.citationMazo, M., Pelacho, B., Prosper, F.Stem Cell Therapy for Chronic Myocardial Infarction. J Cardiovasc Transl Res (2010) 3: 79–88es_ES
dc.identifier.issn1937-5387-
dc.identifier.urihttps://hdl.handle.net/10171/18160-
dc.description.abstractAlthough recent advances for the treatment of myocardial infarction have dramatically increased the rate of survival after the ischemic event, this has also led to a rise in the number of chronic patients, making the finding of a suitable therapy a compulsory subject for modern medicine. Over the last decade, stem cells have been a promise for the cure of several diseases not only due to their plasticity but also to their capacity to act in a paracrine manner and influence the affected tissue, prompting the launching of several clinical trials. In spite of the knowledge already acquired, stem cell application to chronically infarcted hearts has been much less approached than its acute counterpart. Through this review, we will focus in stem cell therapy in animal models of chronic myocardial infarction: cell types employed, functional results, mechanisms analyzed, and questions raised.es_ES
dc.description.sponsorshiphttp://dx.doi.org/10.1007/s12265-009-9159-9-
dc.language.isoenges_ES
dc.publisherSpringer Verlages_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/222995-
dc.rightsinfo:eu-repo/semantics/closedAccess-
dc.subjectChronic myocardial infarctiones_ES
dc.subjectStem celles_ES
dc.subjectAnimal modelses_ES
dc.titleStem Cell Therapy for Chronic Myocardial Infarctiones_ES
dc.typeinfo:eu-repo/semantics/articlees_ES

Files in This Item:
There are no files associated with this item.


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.